PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): A randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction

Canadian Journal of Cardiology

Volumn 12, Issue 11, 1996, Pages 1183-1190

  Goodman, Shaun ^a   Hill, Carol ^a   Bata, Iqbal ^a   Fung, Anthony ^a   Higginson, Lyall ^a   Lam, Jules ^a   Massel, David ^a   McCans, John ^a   Nasmith, James ^a   Stanton, Eric ^a   Thompson, Christopher ^a   Warnica, Wayne ^a   Langer, Anatoly ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Beta blockers; Calcium channel blockers; Non Q wave myocardial infarction; Secondary prevention

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ATENOLOL; CALCIUM CHANNEL BLOCKERS; DEATH, SUDDEN, CARDIAC; DILTIAZEM; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; RECURRENCE;

EID: 10544228955     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Non-Q wave myocardial infarction: recent changes in occurrence and prognosis - a community-wide perspective. Am Heart J 1987;113:273-9.
2. Rouleau JL, Talajic M, Sussex B, et al. Myocardial infarction patients in the 1990s - their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardiat Infarction (CAMI) study. J Am Coll Cardiol 1996;27:1119-27.
3. DeWood MA, Stifter WF, Simpson CS, et al. Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl J Med 1986;315:417-23.
4. Freifield AG, Schuster EH, Healy Bulkley B. Nontransmural versus transmural myocardial infarction. A morphologic study. Am J Med 1983;75:423-32.
5. Keen WD, Savage MP, Fischman DL, et al. Comparison of coronary angiographic findings during the first six hours of non-Q-wave and Q-wave myocardial infarction. Am J Cardiol 1994;74:324-8.
6. Gibson RS. Non-Q-wave myocardial infarction: diagnosis, prognosis, and management. Curr Probl Cardiol 1988;13:1-72.
7. Cohen M, Adams PC, Parry G, et al. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Circulation 1994;89:81-8.
8. Yusuf S, Sleight P, Held P, McMahon S. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials. Circulation 1990;82:II117-34.
9. Overskeid K, Abrahamsen AM, Frisvold OJ, von der Lippe G, Lund-Johansen P, Pedersen TR. Timolol after myocardial infarction. N Engl J Med 1981;305:407. (Lett)
10. Beta-Blocket Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982;247:1707-14.
11. The MIAMI Trial Research Group. MIAMI: Metoprolol in Acute Myocardial Infarction. Mortality. Am J Cardiol 1985;56:15G-22G.
12. Danish Multicenter Study Group on Verapamil in Myocardial Infarction. Verapamil in acute myocardial infarction. Am J Cardiol 1984;54:24E-8E.
13. Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. N Engl J Med 1986;315:423-9.
14. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319:385-92.
15. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II-DAVIT II). Am J Cardiol 1990;66:779-85.
16. The Danish Study Group on Verapamil in Myocardial Infarction. Secondary prevention with verapamil after myocardial infarction Am J Cardiol 1990;66:33I-40I.
17. Dupuis R, Lauzon C, Davies RF, et al. Non-Q-wave myocardial infarction post thrombolysis: What does it really mean? Can J Cardiol 1995;11:109E. (Abst)
18. O'Brien PC, Fleming PR. A multiple testing procedure for clinical trials. Biometrics 1979;33:549-56.
19. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
20. Aguirre FV, Younis LT, Chaitman BR, et al. Early and 1-year clinical outcome of patients' evolving a non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from the TIMI II study. Circulation 1995;91:2541-8.
21. Goodman SG, Langer A, Wildermann N, et al. Non-Q vs. Q wave myocardial infarction post-thrombolysis. angiographie insights. Circulation 1995;92:I530. (Abst)
22. Gibson RS, Beller GA, Gheorghiade M, et al. The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q wave infarction: a prospective natural history study. Circulation 1986;73:1186-98.
23. Hashimoto T, Kambara H, Fudo T, et al. Non-Q wave versus Q wave myocardial infarction: regional myocardial metabolism and blood flow assessed by positron emission tomography. J Am Coll Cardiol 1988;12:88-93.
24. The MIAMI Trial Research Group. MIAMI: Metoprolol in Acute Myocardial Infarction. Development of myocardial infarction. Am J Cardiol 1985;56:23G-6G.
25. Gibson RS. Current status of calcium channel-blocking drugs after Q wave and non-Q wave myocardial infarction. Circulation. 1989;80:IV107-19.
26. Held PH, Yusuf S. Effects of beta-blockers and calcium channel blockers in acute myocardial infarction. Eur Heart J 1993;14:18-25.
27. Koch-Weser J, Frishman WH, Furberg CD, Friedewaid WT. Beta-adrenergic blockade for survivors of acute myocardial infarction. N Engl J Med 1984;310:830-7.
28. Kendall MJ, Lynch KP, Hjalmarson A, Kjekshus J. Beta-blockers and sudden cardiac death. Ann Intern Med 1995;123:358-67.
29. Olsson G, Wikstrand J, Warnold I, et al. Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J 1992;13:28-32.
30. Frishman WH. Current status of calcium channel blockers. Curr Probl Cardiol 1994;19:637-88.
31. Held P, Yusuf S, Furberg C. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ 1989;299:1187-92.
32. Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol I991;67:1295-7.
33. Boden WE, Krone RJ, Kleiger RE, et al. Diltiarem reduces long-term cardiac event rate after non-Q wave infarction: Multicenter Diltiazem Postinfarction Trial (MDPIT). Circulation 1988;319:II96.
34. Boden WE, Krone RJ, Kleiger RE, et al. Electrocardiographs subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. Am J Cardiol 1991;67:335-42.
35. Boden WE. Management of non-Q-wave myocardial infarction: role of diltiazem versus beta-blocker therapy. J Cardiovasc Pharm 1990;16(SuppI 6):S55-60.
36. Boden WE. Meta-analysis in clinical trials reporting: has a tool become a weapon? Am J Cardiol 1992;69:681-6.
37. The Danish Study Group on Verapamil in Myocardial Infarction. The Danish studies on verapamil in myocardial infarction. Br J Clin Pharmacoll 1986;21:197S-204S.
38. Goldstein RE, Boccuzzi SJ, Cruess D, Nattel S, the Adverse Experience Committee, and the Multicenter Diltiazem Postinfarction Research Group, Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 1991;83:52-60.
39. Figulla HR, Gietzen F, Zeymer U, et al. Diltiazem improves cardiac function and exercise capacity in patients with idopathic dilated cardiomyopathy: results of the diltiazem in dilated cardiomyopathy trial. Circulation 1996;94:340-5.
40. Chouhan L, Hajar HA, George T, Pomposiello JC. Non-Q and Q-wave infarction after thrombolytic therapy with intravenous streptokinase for chest pain and anterior ST-segment elevation. Am J Cardiol 1991;68:446-50.
41. The Thrombolysis Early in Acute Heart Attack Trial Study Group. Very early thrombolytic therapy in suspected acute myocardial infarction. Am J Cardiol 1990;65:401-7.
42. Boden WE. Non-Q-wave myocardial infarction: a prognostic paradox. Hosp Pract 1992;27:129-33.